{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T14:27:31Z","timestamp":1760711251037,"version":"3.37.3"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","award":["0301020499QC-W0117"],"award-info":[{"award-number":["0301020499QC-W0117"]}],"id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s11906-023-01269-x","type":"journal-article","created":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T09:02:49Z","timestamp":1696323769000},"page":"471-480","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Key to the Treatment of Primary Aldosteronism in Secondary Hypertension: Subtype Diagnosis"],"prefix":"10.1007","volume":"25","author":[{"given":"Rui","family":"Zuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6601-3208","authenticated-orcid":false,"given":"Hua","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,3]]},"reference":[{"key":"1269_CR1","unstructured":"Conn JW. Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med. 1955;45(1):3\u201317."},{"issue":"22","key":"1269_CR2","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1016\/j.jacc.2019.09.057","volume":"74","author":"GP Rossi","year":"2019","unstructured":"Rossi GP. Primary aldosteronism: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019;74(22):2799\u2013811. https:\/\/doi.org\/10.1016\/j.jacc.2019.09.057.","journal-title":"J Am Coll Cardiol"},{"key":"1269_CR3","doi-asserted-by":"publisher","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(5):1889\u20131916.\u00a0 https:\/\/doi.org\/10.1210\/jc.2015-4061.","DOI":"10.1210\/jc.2015-4061"},{"issue":"12","key":"1269_CR4","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1210\/clinem\/dgaa606","volume":"105","author":"A Vaidya","year":"2020","unstructured":"Vaidya A, Carey RM. Evolution of the primary aldosteronism syndrome: updating the approach. J Clin Endocrinol Metab. 2020;105(12):3771\u201383. https:\/\/doi.org\/10.1210\/clinem\/dgaa606.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1269_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1055\/a-1134-4980","volume":"52","author":"S Gruber","year":"2020","unstructured":"Gruber S, Beuschlein F. Hypokalemia and the prevalence of primary aldosteronism. Horm Metab Res. 2020;52(6):347\u201356. https:\/\/doi.org\/10.1055\/a-1134-4980.","journal-title":"Horm Metab Res"},{"key":"1269_CR6","doi-asserted-by":"publisher","unstructured":"Funder JW. Primary aldosteronism. hypertension. 2019;74(3):458\u2013466. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.119.12935.","DOI":"10.1161\/HYPERTENSIONAHA.119.12935"},{"issue":"1","key":"1269_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1530\/EJE-11-1013","volume":"167","author":"A Hannemann","year":"2012","unstructured":"Hannemann A, Bidlingmaier M, Friedrich N, Manolopoulou J, Spyroglou A, V\u00f6lzke H, et al. Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies. Eur J Endocrinol. 2012;167(1):7\u201315. https:\/\/doi.org\/10.1530\/EJE-11-1013.","journal-title":"Eur J Endocrinol"},{"issue":"16","key":"1269_CR8","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.jacc.2020.02.052","volume":"75","author":"Z Xu","year":"2020","unstructured":"Xu Z, Yang J, Hu J, Song Y, He W, Luo T, et al. Primary aldosteronism in patients in China with recently detected hypertension. J Am Coll Cardiol. 2020;75(16):1913\u201322. https:\/\/doi.org\/10.1016\/j.jacc.2020.02.052.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"1269_CR9","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/S2213-8587(21)00210-2","volume":"9","author":"M Reincke","year":"2021","unstructured":"Reincke M, Bancos I, Mulatero P, Scholl UI, Stowasser M, Williams TA. Diagnosis and treatment of primary aldosteronism. Lancet Diabetes Endocrinol. 2021;9(12):876\u201392. https:\/\/doi.org\/10.1016\/S2213-8587(21)00210-2.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"1269_CR10","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1161\/HYPERTENSIONAHA.117.10596","volume":"71","author":"GP Rossi","year":"2018","unstructured":"Rossi GP, Maiolino G, Flego A, Belfiore A, Bernini G, Fabris B, et al. Adrenalectomy lowers incident atrial fibrillation in primary aldosteronism patients at long term. Hypertension. 2018;71(4):585\u201391. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.10596.","journal-title":"Hypertension"},{"issue":"7","key":"1269_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11886-021-01516-0","volume":"23","author":"H Wachtel","year":"2021","unstructured":"Wachtel H, Fraker DL. Therapeutic outcomes with surgical and medical management of primary aldosteronism. Curr Cardiol Rep. 2021;23(7):89. https:\/\/doi.org\/10.1007\/s11886-021-01516-0.","journal-title":"Curr Cardiol Rep"},{"issue":"4","key":"1269_CR12","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/S2213-8587(14)70069-5","volume":"3","author":"S Monticone","year":"2015","unstructured":"Monticone S, Viola A, Rossato D, Veglio F, Reincke M, Gomez-Sanchez C, et al. Adrenal vein sampling in primary aldosteronism: towards a standardised protocol. Lancet Diabetes Endocrinol. 2015;3(4):296\u2013303. https:\/\/doi.org\/10.1016\/S2213-8587(14)70069-5.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"1269_CR13","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1210\/jc.2002-022051","volume":"88","author":"EA Espiner","year":"2003","unstructured":"Espiner EA, Ross DG, Yandle TG, Richards AM, Hunt PJ. Predicting surgically remedial primary aldosteronism: role of adrenal scanning, posture testing, and adrenal vein sampling. J Clin Endocrinol Metab. 2003;88(8):3637\u201344. https:\/\/doi.org\/10.1210\/jc.2002-022051.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1269_CR14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2214\/ajr.141.2.299","volume":"141","author":"MA Geisinger","year":"1983","unstructured":"Geisinger MA, Zelch MG, Bravo EL, Risius BF, O\u2019Donovan PB, Borkowski GP. Primary hyperaldosteronism: comparison of CT, adrenal venography, and venous sampling. AJR Am J Roentgenol. 1983;141(2):299\u2013302. https:\/\/doi.org\/10.2214\/ajr.141.2.299.","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"1269_CR15","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1148\/radiology.184.3.1509049","volume":"184","author":"JL Doppman","year":"1992","unstructured":"Doppman JL, Gill JR Jr, Miller DL, Chang R, Gupta R, Friedman TC, et al. Distinction between hyperaldosteronism due to bilateral hyperplasia and unilateral aldosteronoma: reliability of CT. Radiology. 1992;184(3):677\u201382. https:\/\/doi.org\/10.1148\/radiology.184.3.1509049.","journal-title":"Radiology"},{"issue":"4","key":"1269_CR16","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1210\/jc.2007-2055","volume":"93","author":"P Mulatero","year":"2008","unstructured":"Mulatero P, Bertello C, Rossato D, Mengozzi G, Milan A, Garrone C, et al. Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes. J Clin Endocrinol Metab. 2008;93(4):1366\u201371. https:\/\/doi.org\/10.1210\/jc.2007-2055.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1269_CR17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.7326\/0003-4819-151-5-200909010-00007","volume":"151","author":"MJ Kempers","year":"2009","unstructured":"Kempers MJ, Lenders JW, van Outheusden L, van der Wilt GJ, Schultze Kool LJ, Hermus AR, et al. Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism. Ann Intern Med. 2009;151(5):329\u201337. https:\/\/doi.org\/10.7326\/0003-4819-151-5-200909010-00007.","journal-title":"Ann Intern Med"},{"issue":"12","key":"1269_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-038489","volume":"10","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Wang D, Jiang L, Ran F, Chen S, Zhou P, et al. Diagnostic accuracy of adrenal imaging for subtype diagnosis in primary aldosteronism: systematic review and meta-analysis. BMJ Open. 2020;10(12):e038489. https:\/\/doi.org\/10.1136\/bmjopen-2020-038489.","journal-title":"BMJ Open"},{"issue":"12","key":"1269_CR19","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1038\/s41440-019-0310-y","volume":"42","author":"D Aono","year":"2019","unstructured":"Aono D, Kometani M, Karashima S, Usukura M, Gondo Y, Hashimoto A, et al. Primary aldosteronism subtype discordance between computed tomography and adrenal venous sampling. Hypertens Res. 2019;42(12):1942\u201350. https:\/\/doi.org\/10.1038\/s41440-019-0310-y.","journal-title":"Hypertens Res"},{"issue":"8","key":"1269_CR20","doi-asserted-by":"publisher","first-page":"830","DOI":"10.4158\/EP-2019-0009","volume":"25","author":"S Li","year":"2019","unstructured":"Li S, Ren Y, Zhu Y, Sun H, Ma L, Tian H, et al. The potential clinical application of a lower bilateral adrenal limb width ratio (L\/RW) in patients with bilateral primary hyperaldosteronism. Endocr Pract. 2019;25(8):830\u20135. https:\/\/doi.org\/10.4158\/EP-2019-0009.","journal-title":"Endocr Pract"},{"key":"1269_CR21","doi-asserted-by":"publisher","unstructured":"Araujo-Castro M, Parra-Ram\u00edrez P. Diagnosis of primary hyperaldosteronism. Med Clin (Barc). 2022;158(9):424\u2013430. English, Spanish. https:\/\/doi.org\/10.1016\/j.medcli.2021.10.012.","DOI":"10.1016\/j.medcli.2021.10.012"},{"issue":"3","key":"1269_CR22","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1210\/jc.2017-01774","volume":"103","author":"H Umakoshi","year":"2018","unstructured":"Umakoshi H, Tsuiki M, Takeda Y, Kurihara I, Itoh H, Katabami T, et al. Significance of computed tomography and serum potassium in predicting subtype diagnosis of primary aldosteronism. J Clin Endocrinol Metab. 2018;103(3):900\u20138. https:\/\/doi.org\/10.1210\/jc.2017-01774. PMID: 29092077.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1269_CR23","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1210\/jc.2018-02089","volume":"104","author":"D Sam","year":"2019","unstructured":"Sam D, Kline GA, So B, Leung AA. Discordance between imaging and adrenal vein sampling in primary aldosteronism irrespective of interpretation criteria. J Clin Endocrinol Metab. 2019;104(6):1900\u20136. https:\/\/doi.org\/10.1210\/jc.2018-02089.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1269_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.944035","volume":"16","author":"M Zhang","year":"2022","unstructured":"Zhang M, Bian G, Tian J, Yang W, Wang X, Chi C. Assessment of biochemical outcomes in patients with primary aldosteronism after adrenalectomy based on CT scan diagnosis of unilateral adenoma without adrenal vein sampling. Front Oncol. 2022;16(12): 944035. https:\/\/doi.org\/10.3389\/fonc.2022.944035.","journal-title":"Front Oncol"},{"issue":"2","key":"1269_CR25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1089\/lap.2022.0302","volume":"33","author":"D Asbun","year":"2023","unstructured":"Asbun D, Cheng YL, Bush W, Samson SL, Meek S, Paz-Fumagalli R, et al. Eleven-year experience with selective adrenal vein sampling in management of primary adrenal hormonal hypersecretion. J Laparoendosc Adv Surg Tech A. 2023;33(2):129\u201336. https:\/\/doi.org\/10.1089\/lap.2022.0302.","journal-title":"J Laparoendosc Adv Surg Tech A"},{"issue":"5","key":"1269_CR26","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/eci.12746","volume":"47","author":"R Ladurner","year":"2017","unstructured":"Ladurner R, Sommerey S, Buechner S, Dietz A, Degenhart C, Hallfeldt K, et al. Accuracy of adrenal imaging and adrenal venous sampling in diagnosing unilateral primary aldosteronism. Eur J Clin Invest. 2017;47(5):372\u20137. https:\/\/doi.org\/10.1111\/eci.12746.","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"1269_CR27","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.3390\/tomography8060228","volume":"8","author":"I Tizianel","year":"2022","unstructured":"Tizianel I, Sabbadin C, Mian C, Scaroni C, Ceccato F. Imaging or adrenal vein sampling approach in primary aldosteronism? A patient-based approach Tomography. 2022;8(6):2735\u201348. https:\/\/doi.org\/10.3390\/tomography8060228.","journal-title":"A patient-based approach Tomography"},{"issue":"9","key":"1269_CR28","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2213-8587(16)30100-0","volume":"4","author":"T Dekkers","year":"2016","unstructured":"Dekkers T, Prejbisz A, Kool LJS, Groenewoud HJMM, Velema M, Spiering W, et al. Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial. Lancet Diabetes Endocrinol. 2016;4(9):739\u201346. https:\/\/doi.org\/10.1016\/S2213-8587(16)30100-0.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"1269_CR29","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/jch.14395","volume":"24","author":"Y Yan","year":"2022","unstructured":"Yan Y, Sun HW, Qi Y. Prognosis of adrenalectomy guided by computed tomography versus adrenal vein sampling in patients with primary aldosteronism: a systematic review and meta-analysis. J Clin Hypertens (Greenwich). 2022;24(2):106\u201315. https:\/\/doi.org\/10.1111\/jch.14395.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"2","key":"1269_CR30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.7861\/clinmed.2023-0042","volume":"23","author":"DJ Cuthbertson","year":"2023","unstructured":"Cuthbertson DJ, Alam U, Davison AS, Belfield J, Shore SL, Vinjamuri S. Investigation and assessment of adrenal incidentalomas. Clin Med (Lond). 2023;23(2):135\u201340. https:\/\/doi.org\/10.7861\/clinmed.2023-0042.","journal-title":"Clin Med (Lond)"},{"issue":"3","key":"1269_CR31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/MED.0000000000000407","volume":"25","author":"GP Rossi","year":"2018","unstructured":"Rossi GP. Update in adrenal venous sampling for primary aldosteronism. Curr Opin Endocrinol Diabetes Obes. 2018;25(3):160\u201371. https:\/\/doi.org\/10.1097\/MED.0000000000000407.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"10","key":"1269_CR32","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1097\/HJH.0000000000002510","volume":"38","author":"P Mulatero","year":"2020","unstructured":"Mulatero P, Monticone S, Deinum J, Amar L, Prejbisz A, Zennaro MC, et al. Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension. J Hypertens. 2020;38(10):1919\u201328. https:\/\/doi.org\/10.1097\/HJH.0000000000002510.","journal-title":"J Hypertens"},{"issue":"4","key":"1269_CR33","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1507\/endocrj.EJ21-0508","volume":"69","author":"M Naruse","year":"2022","unstructured":"Naruse M, Katabami T, Shibata H, Sone M, Takahashi K, Tanabe A, et al. Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021. Endocr J. 2022;69(4):327\u201359. https:\/\/doi.org\/10.1507\/endocrj.EJ21-0508.","journal-title":"Endocr J"},{"issue":"1","key":"1269_CR34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","volume":"63","author":"GP Rossi","year":"2014","unstructured":"Rossi GP, Auchus RJ, Brown M, Lenders JW, Naruse M, Plouin PF, et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension. 2014;63(1):151\u201360. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.113.02097.","journal-title":"Hypertension"},{"issue":"1","key":"1269_CR35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.113.01316","volume":"62","author":"GP Rossi","year":"2013","unstructured":"Rossi GP, Cesari M, Cuspidi C, Maiolino G, Cicala MV, Bisogni V, et al. Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism. Hypertension. 2013;62(1):62\u20139. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.113.01316.","journal-title":"Hypertension"},{"issue":"3","key":"1269_CR36","doi-asserted-by":"publisher","first-page":"D15","DOI":"10.1530\/EJE-18-0844","volume":"181","author":"J Deinum","year":"2019","unstructured":"Deinum J, Groenewoud H, van der Wilt GJ, Lenzini L, Rossi GP. Adrenal venous sampling: cosyntropin stimulation or not? Eur J Endocrinol. 2019;181(3):D15\u201326. https:\/\/doi.org\/10.1530\/EJE-18-0844.","journal-title":"Eur J Endocrinol"},{"key":"1269_CR37","doi-asserted-by":"publisher","unstructured":"Loberg C, Antoch G, Stegbauer J, Dringenberg T, Steuwe A, F\u00fcrst G et al. Update: selective adrenal venous sampling (AVS) - indication, technique, and significance. Rofo. 2021;193(6):658\u2013666. English, German. https:\/\/doi.org\/10.1055\/a-1299-1878.","DOI":"10.1055\/a-1299-1878"},{"key":"1269_CR38","doi-asserted-by":"publisher","unstructured":"Lightman SL, Birnie MT, Conway-Campbell BL. Dynamics of ACTH and cortisol secretion and implications for disease. Endocr Rev. 2020;41(3):bnaa002. https:\/\/doi.org\/10.1210\/endrev\/bnaa002.","DOI":"10.1210\/endrev\/bnaa002"},{"issue":"9","key":"1269_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14438","volume":"75","author":"J Yang","year":"2021","unstructured":"Yang J, Yu Y, Zhang Z, Wu Y, He Z. Adrenal venous sampling with adrenocorticotropic hormone stimulation: a meta-analysis. Int J Clin Pract. 2021;75(9):e14438. https:\/\/doi.org\/10.1111\/ijcp.14438.","journal-title":"Int J Clin Pract"},{"issue":"5","key":"1269_CR40","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1161\/HYPERTENSIONAHA.108.128553","volume":"53","author":"TM Seccia","year":"2009","unstructured":"Seccia TM, Miotto D, De Toni R, Pitter G, Mantero F, Pessina AC, et al. Adrenocorticotropic hormone stimulation during adrenal vein sampling for identifying surgically curable subtypes of primary aldosteronism: comparison of 3 different protocols. Hypertension. 2009;53(5):761\u20136. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.108.128553.","journal-title":"Hypertension"},{"issue":"4","key":"1269_CR41","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1161\/HYPERTENSIONAHA.111.189548","volume":"59","author":"S Monticone","year":"2012","unstructured":"Monticone S, Satoh F, Giacchetti G, Viola A, Morimoto R, Kudo M, et al. Effect of adrenocorticotropic hormone stimulation during adrenal vein sampling in primary aldosteronism. Hypertension. 2012;59(4):840\u20136. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.111.189548.","journal-title":"Hypertension"},{"issue":"12","key":"1269_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.784706","volume":"26","author":"J Hu","year":"2021","unstructured":"Hu J, Chen J, Cheng Q, Jing Y, Yang J, Du Z, et al. Comparison of bolus and continuous infusion of adrenocorticotropic hormone during adrenal vein sampling. Front Endocrinol (Lausanne). 2021;26(12):784706. https:\/\/doi.org\/10.3389\/fendo.2021.784706.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"1269_CR43","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1245\/s10434-011-2121-5","volume":"19","author":"R Webb","year":"2012","unstructured":"Webb R, Mathur A, Chang R, Baid S, Nilubol N, Libutti SK, et al. What is the best criterion for the interpretation of adrenal vein sample results in patients with primary hyperaldosteronism? Ann Surg Oncol. 2012;19(6):1881\u20136. https:\/\/doi.org\/10.1245\/s10434-011-2121-5.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"1269_CR44","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1161\/HYPERTENSIONAHA.110.168484","volume":"57","author":"O Vonend","year":"2011","unstructured":"Vonend O, Ockenfels N, Gao X, Allolio B, Lang K, Mai K, et al. Adrenal venous sampling: evaluation of the German Conn\u2019s registry. Hypertension. 2011;57(5):990\u20135. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.110.168484.","journal-title":"Hypertension"},{"issue":"12","key":"1269_CR45","doi-asserted-by":"publisher","first-page":"5006","DOI":"10.1007\/s00330-017-4930-9","volume":"27","author":"CC Chang","year":"2017","unstructured":"Chang CC, Lee BC, Chang YC, Wu VC, Huang KH, Liu KL, et al. Comparison of C-arm computed tomography and on-site quick cortisol assay for adrenal venous sampling: a retrospective study of 178 patients. Eur Radiol. 2017;27(12):5006\u201314. https:\/\/doi.org\/10.1007\/s00330-017-4930-9.","journal-title":"Eur Radiol"},{"issue":"3","key":"1269_CR46","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/ans.17352","volume":"92","author":"MP Sawyer","year":"2022","unstructured":"Sawyer MP, Yong EXZ, Marginson B, Farrell SG, Derbyshire MM, MacIsaac RJ, et al. Utility of semi-quantitative quick cortisol assay with low-dose adrenocorticotropic hormone infusion adrenal vein sampling. ANZ J Surg. 2022;92(3):437\u201342. https:\/\/doi.org\/10.1111\/ans.17352.","journal-title":"ANZ J Surg"},{"issue":"6","key":"1269_CR47","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1210\/jc.2016-1011","volume":"101","author":"T Yoneda","year":"2016","unstructured":"Yoneda T, Karashima S, Kometani M, Usukura M, Demura M, Sanada J, et al. Impact of new quick gold nanoparticle-based cortisol assay during adrenal vein sampling for primary aldosteronism. J Clin Endocrinol Metab. 2016;101(6):2554\u201361. https:\/\/doi.org\/10.1210\/jc.2016-1011.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1269_CR48","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3803\/EnM.2018.33.2.236","volume":"33","author":"CH Park","year":"2018","unstructured":"Park CH, Hong N, Han K, Kang SW, Lee CR, Park S, et al. C-arm computed tomography-assisted adrenal venous sampling improved right adrenal vein cannulation and sampling quality in primary aldosteronism. Endocrinol Metab (Seoul). 2018;33(2):236\u201344. https:\/\/doi.org\/10.3803\/EnM.2018.33.2.236.","journal-title":"Endocrinol Metab (Seoul)"},{"key":"1269_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2019.108792","volume":"124","author":"O Meyrignac","year":"2020","unstructured":"Meyrignac O, Arcis \u00c9, Delchier MC, Mokrane FZ, Darcourt J, Rousseau H, et al. Impact of cone beam - CT on adrenal vein sampling in primary aldosteronism. Eur J Radiol. 2020;124: 108792. https:\/\/doi.org\/10.1016\/j.ejrad.2019.108792.","journal-title":"Eur J Radiol"},{"issue":"4","key":"1269_CR50","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00270-014-0969-z","volume":"38","author":"WM Busser","year":"2015","unstructured":"Busser WM, Arntz MJ, Jenniskens SF, Deinum J, Hoogeveen YL, et al. Image registration of cone-beam computer tomography and preprocedural computer tomography aids in localization of adrenal veins and decreasing radiation dose in adrenal vein sampling. Cardiovasc Intervent Radiol. 2015;38(4):993\u20137. https:\/\/doi.org\/10.1007\/s00270-014-0969-z.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1","key":"1269_CR51","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12880-022-00911-5","volume":"22","author":"R Cai","year":"2022","unstructured":"Cai R, Hu C, Li HY. Cone-beam computed tomography is not a mandatory procedure in adrenal venous sampling for primary hyperaldosteronism. BMC Med Imaging. 2022;22(1):189. https:\/\/doi.org\/10.1186\/s12880-022-00911-5.","journal-title":"BMC Med Imaging"},{"issue":"2","key":"1269_CR52","doi-asserted-by":"publisher","first-page":"190","DOI":"10.2214\/AJR.22.27692","volume":"220","author":"KB Quencer","year":"2023","unstructured":"Quencer KB, Singh A, Sharma A. Best practices: indications and procedural controversies of adrenal vein sampling for primary aldosteronism. AJR Am J Roentgenol. 2023;220(2):190\u2013200. https:\/\/doi.org\/10.2214\/AJR.22.27692.","journal-title":"AJR Am J Roentgenol"},{"issue":"441","key":"1269_CR53","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.mce.2016.10.014","volume":"5","author":"K Nishimoto","year":"2017","unstructured":"Nishimoto K, Koga M, Seki T, Oki K, Gomez-Sanchez EP, Gomez-Sanchez CE, et al. Immunohistochemistry of aldosterone synthase leads the way to the pathogenesis of primary aldosteronism. Mol Cell Endocrinol. 2017;5(441):124\u201333. https:\/\/doi.org\/10.1016\/j.mce.2016.10.014.","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"1269_CR54","first-page":"275","volume":"41","author":"M Bergstr\u00f6m","year":"2000","unstructured":"Bergstr\u00f6m M, Juhlin C, Bonasera TA, Sundin A, Rastad J, Akerstr\u00f6m G, et al. PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11C-metomidate. J Nucl Med. 2000;41(2):275\u201382.","journal-title":"J Nucl Med"},{"issue":"6","key":"1269_CR55","first-page":"982","volume":"39","author":"M Bergstr\u00f6m","year":"1998","unstructured":"Bergstr\u00f6m M, Bonasera TA, Lu L, Bergstr\u00f6m E, Backlin C, Juhlin C, et al. In vitro and in vivo primate evaluation of carbon-11-etomidate and carbon-11-metomidate as potential tracers for PET imaging of the adrenal cortex and its tumors. J Nucl Med. 1998;39(6):982\u20139.","journal-title":"J Nucl Med"},{"issue":"4","key":"1269_CR56","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1210\/jc.2005-2273","volume":"91","author":"J Hennings","year":"2006","unstructured":"Hennings J, Lindhe O, Bergstr\u00f6m M, L\u00e5ngstr\u00f6m B, Sundin A, Hellman P. [11C]metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings. J Clin Endocrinol Metab. 2006;91(4):1410\u20134. https:\/\/doi.org\/10.1210\/jc.2005-2273.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1269_CR57","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1007\/s00259-004-1575-0","volume":"31","author":"G Zettinig","year":"2004","unstructured":"Zettinig G, Mitterhauser M, Wadsak W, Becherer A, Pirich C, Vierhapper H, et al. Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate. Eur J Nucl Med Mol Imaging. 2004;31(9):1224\u201330. https:\/\/doi.org\/10.1007\/s00259-004-1575-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"1269_CR58","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1210\/jc.2011-1537","volume":"97","author":"TJ Burton","year":"2012","unstructured":"Burton TJ, Mackenzie IS, Balan K, Koo B, Bird N, Soloviev DV, et al. Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn\u2019s adenomas. J Clin Endocrinol Metab. 2012;97(1):100\u20139. https:\/\/doi.org\/10.1210\/jc.2011-1537.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1269_CR59","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s12020-020-02474-3","volume":"70","author":"SM Chen Cardenas","year":"2020","unstructured":"Chen Cardenas SM, Santhanam P. 11C-metomidate PET in the diagnosis of adrenal masses and primary aldosteronism: a review of the literature. Endocrine. 2020;70(3):479\u201387. https:\/\/doi.org\/10.1007\/s12020-020-02474-3.","journal-title":"Endocrine"},{"issue":"5","key":"1269_CR60","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/cen.13942","volume":"90","author":"PM O'Shea","year":"2019","unstructured":"O\u2019Shea PM, O\u2019Donoghue D, Bashari W, Senanayake R, Joyce MB, Powlson AS, et al. 11 C-Metomidate PET\/CT is a useful adjunct for lateralization of primary aldosteronism in routine clinical practice. Clin Endocrinol (Oxf). 2019;90(5):670\u20139. https:\/\/doi.org\/10.1111\/cen.13942.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"1269_CR61","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1530\/EJE-20-0532","volume":"183","author":"M Soinio","year":"2020","unstructured":"Soinio M, Luukkonen AK, Sepp\u00e4nen M, Kemppainen J, Sepp\u00e4nen J, Pienim\u00e4ki JP, et al. Functional imaging with 11C-metomidate PET for subtype diagnosis in primary aldosteronism. Eur J Endocrinol. 2020;183(6):539\u201350. https:\/\/doi.org\/10.1530\/EJE-20-0532.","journal-title":"Eur J Endocrinol"},{"key":"1269_CR62","doi-asserted-by":"publisher","unstructured":"O' Doherty J, O' Doherty S, Robins EG, Reilhac A. Parametric mapping for 11C-metomidate PET-computed tomography imaging in the study of primary aldosteronism. Nucl Med Commun. 2021. https:\/\/doi.org\/10.1097\/MNM.0000000000001477.","DOI":"10.1097\/MNM.0000000000001477"},{"issue":"6","key":"1269_CR63","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1097\/HJH.0000000000003132","volume":"40","author":"TH Puar","year":"2022","unstructured":"Puar TH, Khoo CM, Tan CJ, Tong AKT, Tan MCS, Teo AE, et al. 11C-Metomidate PET-CT versus adrenal vein sampling to subtype primary aldosteronism: a prospective clinical trial. J Hypertens. 2022;40(6):1179\u201388. https:\/\/doi.org\/10.1097\/HJH.0000000000003132.","journal-title":"J Hypertens"},{"issue":"11","key":"1269_CR64","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/RLU.0000000000004369","volume":"47","author":"CC Lu","year":"2022","unstructured":"Lu CC, Chen CJ, Peng KY, Chueh JS, Chang CC, Yen RF, et al. Predicting treatment response in primary aldosteronism using 11 C-metomidate positron emission tomography. Clin Nucl Med. 2022;47(11):936\u201342. https:\/\/doi.org\/10.1097\/RLU.0000000000004369.","journal-title":"Clin Nucl Med"},{"issue":"1","key":"1269_CR65","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41591-022-02114-5","volume":"29","author":"X Wu","year":"2023","unstructured":"\u2022 Wu X, Senanayake R, Goodchild E, Bashari WA, Salsbury J, Cabrera CP, et al. [11C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial. Nat Med. 2023;29(1):190\u2013202. https:\/\/doi.org\/10.1038\/s41591-022-02114-5. Findings from this study suggest that 1111C-MTO PET\/CT is as accurate in the prediction of outcomes from adrenalectomy as the standard, invasive investigation, AVS and enables non-invasive diagnosis of unilateral PA.","journal-title":"Nat Med"},{"issue":"3","key":"1269_CR66","doi-asserted-by":"publisher","first-page":"L9","DOI":"10.1530\/EJE-20-1402","volume":"184","author":"F Crim\u00ec","year":"2021","unstructured":"Crim\u00ec F, Spimpolo A, Cecchin D, Rossi GP. Functional imaging by 11C-metomidate PET: a really useless technique for primary aldosteronism subtyping? Eur J Endocrinol. 2021;184(3):L9\u201310. https:\/\/doi.org\/10.1530\/EJE-20-1402.","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"1269_CR67","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.7150\/ijms.51206","volume":"18","author":"I Silins","year":"2021","unstructured":"Silins I, Sundin A, Nordeman P, Jahan M, Estrada S, Monazzam A, et al. Para-chloro-2-[18F]fluoroethyl-etomidate: a promising new PET radiotracer for adrenocortical imaging. Int J Med Sci. 2021;18(10):2187\u201396. https:\/\/doi.org\/10.7150\/ijms.51206.","journal-title":"Int J Med Sci"},{"issue":"2","key":"1269_CR68","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s00259-022-05957-9","volume":"50","author":"I Silins","year":"2023","unstructured":"Silins I, Sundin A, Lubberink M, O\u2019Sullivan L, Gurnell M, Aigbirhio F, et al. First-in-human evaluation of [18F]CETO: a novel tracer for adrenocortical tumours. Eur J Nucl Med Mol Imaging. 2023;50(2):398\u2013409. https:\/\/doi.org\/10.1007\/s00259-022-05957-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"1269_CR69","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/diagnostics6040042","volume":"6","author":"IA Mendichovszky","year":"2016","unstructured":"Mendichovszky IA, Powlson AS, Manavaki R, Aigbirhio FI, Cheow H, Buscombe JR, et al. Targeted molecular imaging in adrenal disease-an emerging role for metomidate PET-CT. Diagnostics (Basel). 2016;6(4):42. https:\/\/doi.org\/10.3390\/diagnostics6040042.","journal-title":"Diagnostics (Basel)"},{"key":"1269_CR70","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/B978-0-12-411638-2.00002-1","volume":"124","author":"S Chatterjee","year":"2014","unstructured":"Chatterjee S, Behnam Azad B, Nimmagadda S. The intricate role of CXCR4 in cancer. Adv Cancer Res. 2014;124:31\u201382. https:\/\/doi.org\/10.1016\/B978-0-12-411638-2.00002-1.","journal-title":"Adv Cancer Res"},{"issue":"2","key":"1269_CR71","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1161\/HYPERTENSIONAHA.117.09975","volume":"71","author":"B Heinze","year":"2018","unstructured":"Heinze B, Fuss CT, Mulatero P, Beuschlein F, Reincke M, Mustafa M, et al. Targeting CXCR4 (CXC chemokine receptor type 4) for molecular imaging of aldosterone-producing adenoma. Hypertension. 2018;71(2):317\u201325. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.09975.","journal-title":"Hypertension"},{"issue":"11","key":"1269_CR72","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1007\/s00259-020-04722-0","volume":"47","author":"J Ding","year":"2020","unstructured":"Ding J, Zhang Y, Wen J, Zhang H, Wang H, Luo Y, et al. Imaging CXCR4 expression in patients with suspected primary hyperaldosteronism. Eur J Nucl Med Mol Imaging. 2020;47(11):2656\u201365. https:\/\/doi.org\/10.1007\/s00259-020-04722-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"1269_CR73","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1007\/s00330-022-09058-x","volume":"33","author":"Y Gao","year":"2023","unstructured":"Gao Y, Ding J, Cui Y, Li T, Sun H, Zhao D, et al. Functional nodules in primary aldosteronism: identification of CXCR4 expression with 68Ga-pentixafor PET\/CT. Eur Radiol. 2023;33(2):996\u20131003. https:\/\/doi.org\/10.1007\/s00330-022-09058-x.","journal-title":"Eur Radiol"},{"issue":"2","key":"1269_CR74","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.55609","volume":"6","author":"J Hu","year":"2023","unstructured":"\u2022 Hu J, Xu T, Shen H, Song Y, Yang J, Zhang A, et al. Accuracy of gallium-68 pentixafor positron emission tomography-computed tomography for subtyping diagnosis of primary aldosteronism. JAMA Netw Open. 2023;6(2):e2255609. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.55609. This study first evaluates the accuracy of 6868Ga-pentixafor PET-CT in subtyping PA and finds that 6868Ga-pentixafor PET-CT facilitate PA subtyping diagnosis, and it may be an accurate and noninvasive alternative to AVS.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"1269_CR75","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1365-2265.2011.04202.x","volume":"76","author":"JH Lau","year":"2012","unstructured":"Lau JH, Sze WC, Reznek RH, Matson M, Sahdev A, Carpenter R, et al. A prospective evaluation of postural stimulation testing, computed tomography and adrenal vein sampling in the differential diagnosis of primary aldosteronism. Clin Endocrinol (Oxf). 2012;76(2):182\u20138. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04202.x.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"1269_CR76","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1365-2265.1994.tb02550.x","volume":"41","author":"T Feltynowski","year":"1994","unstructured":"Feltynowski T, Ignatowska-Switalska H, Wocial B, Lewandowski J, Chodakowska J, Januszewicz W. Postural stimulation test in patients with aldosterone producing adenomas. Clin Endocrinol (Oxf). 1994;41(3):309\u201314. https:\/\/doi.org\/10.1111\/j.1365-2265.1994.tb02550.x.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"1269_CR77","doi-asserted-by":"publisher","first-page":"4526","DOI":"10.1210\/jcem.85.12.7086","volume":"85","author":"JL Phillips","year":"2000","unstructured":"Phillips JL, Walther MM, Pezzullo JC, Rayford W, Choyke PL, Berman AA, et al. Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma. J Clin Endocrinol Metab. 2000;85(12):4526\u201333. https:\/\/doi.org\/10.1210\/jcem.85.12.7086.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1269_CR78","doi-asserted-by":"publisher","first-page":"R101","DOI":"10.1530\/EJE-17-0946","volume":"178","author":"S Monticone","year":"2018","unstructured":"Monticone S, Buffolo F, Tetti M, Veglio F, Pasini B, Mulatero P. Genetics in endocrinology: the expanding genetic horizon of primary aldosteronism. Eur J Endocrinol. 2018;178(3):R101\u201311. https:\/\/doi.org\/10.1530\/EJE-17-0946.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"1269_CR79","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1210\/jc.2011-2384","volume":"97","author":"P Mulatero","year":"2012","unstructured":"Mulatero P, di Cella SM, Monticone S, Schiavone D, Manzo M, Mengozzi G, et al. 18-Hydroxycorticosterone, 18-hydroxycortisol, and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes. J Clin Endocrinol Metab. 2012;97(3):881\u20139. https:\/\/doi.org\/10.1210\/jc.2011-2384.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1269_CR80","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1210\/jc.2006-2631","volume":"92","author":"RJ Auchus","year":"2007","unstructured":"Auchus RJ, Chandler DW, Singeetham S, Chokshi N, Nwariaku FE, Dolmatch BL, et al. Measurement of 18-hydroxycorticosterone during adrenal vein sampling for primary aldosteronism. J Clin Endocrinol Metab. 2007;92(7):2648\u201351. https:\/\/doi.org\/10.1210\/jc.2006-2631.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-023-01269-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11906-023-01269-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-023-01269-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T19:05:31Z","timestamp":1701803131000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11906-023-01269-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,3]]},"references-count":80,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1269"],"URL":"https:\/\/doi.org\/10.1007\/s11906-023-01269-x","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"type":"print","value":"1522-6417"},{"type":"electronic","value":"1534-3111"}],"subject":[],"published":{"date-parts":[[2023,10,3]]},"assertion":[{"value":"12 September 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical\u00a0Standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}